All lobbying filings

THE VOGEL GROUP

THE VOGEL GROUP filed a Q2 report for NEPHRON PHARMACEUTICALS CORPORATION on July 19, 2026, reporting $50,000 in lobbying income.

Lobbying for NEPHRON PHARMACEUTICALS CORPORATION · Developer and manufacturer of sterile inhalation and 503B outsourcing medication.

All filings by THE VOGEL GROUP · Everything NEPHRON PHARMACEUTICALS CORPORATION has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 19, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

South Carolina

Official filing document

Lobbyists on this filing 1

ALEXANDER NICHOLAS VOGEL SR

Previously held: Former Chief Counsel, Senate Majority Leader Bill Frist

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 1

Health & Human Services, Dept of (HHS)

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Pharmacy

Issues relating to facility operations

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.